Streetbeat News

AHG

Akso Health Group

https://www.xiaobaimaimai.com

Industry

Financial - Credit Services

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

The article highlights significant intraday movements in health care stocks on Thursday. Notable gainers include Qualigen Therapeutics (QLGN), Sharps Technology (STSS), and Autonomix Medical (AMIX), while Reshape Lifesciences (RSLS) and CNS Pharma (CNSP) were among the losers.

Portfolio Pulse from Benzinga Insights

July 05, 2024 | 3:00 pm

The article highlights significant intraday movements in health care stocks on Thursday. Notable gainers include Virax Biolabs Group (VRAX), FibroBiologics (FBLG), Aethlon Medical (AEMD), American Oncology Network (AONC), Replimune Group (REPL), and Co-Diagnostics (CODX). On the losing side, Ventyx Biosciences (VTYX), Fresh2 Group (FRES), ENDRA Life Sciences (NDRA), Kineta (KA), 4D Molecular Therapeutics (FDMT), and Akso Health Group (AHG) saw declines.

Portfolio Pulse from Benzinga Insights

June 06, 2024 | 4:31 pm

The article highlights the pre-market movements of 12 health care stocks on Friday. Notable gainers include Cue Health (HLTH), Innovative Eyewear (LUCY), SCWorx (WORX), Arcus Biosciences (RCUS), Biora Therapeutics (BIOR), and Jin Medical International (ZJYL). Significant losers include Verastem (VSTM), Sensei Biotherapeutics (SNSE), Genelux (GNLX), Summit Therapeutics (SMMT), Akari Therapeutics (AKTX), and Akso Health Group (AHG).

Portfolio Pulse from Benzinga Insights

May 24, 2024 | 12:07 pm

The article highlights significant intraday movements in health care stocks on Wednesday. Notable gainers include IGM Biosciences (IGMS), Akso Health Group (AHG), MultiPlan (MPLN), Cyclerion Therapeutics (CYCN), TransCode Therapeutics (RNAZ), and Indaptus Therapeutics (INDP). On the losing side, Biodexa Pharmaceuticals (BDRX), Oragenics (OGEN), LifeStance Health Group (LFST), Mustang Bio (MBIO), Eagle Pharmaceuticals (EGRX), and GT Biopharma (GTBP) saw substantial declines.

Portfolio Pulse from Benzinga Insights

May 22, 2024 | 4:31 pm

In Wednesday's pre-market session, several health care stocks experienced significant movements. Mustang Bio (MBIO) saw a 51.6% increase, while NeuroBo Pharmaceuticals (NRBO) rose by 30.78%. Rezolute (RZLT) and Akso Health Group (AHG) also saw gains of 25.0% and 16.26%, respectively. On the losing side, LifeStance Health Group (LFST) declined by 18.6%, and Lipella Pharmaceuticals (LIPO) fell by 11.84%.

Portfolio Pulse from Benzinga Insights

May 22, 2024 | 12:06 pm

The article highlights the performance of various health care stocks during Friday's after-market session. Notable gainers include Akso Health Group, China SXT Pharmaceuticals, CareCloud, Eledon Pharma, OneMedNet, and Reshape Lifesciences. On the losing side, Jaguar Health, Akanda, Virios Therapeutics, Revelation Biosciences, Lixte Biotechnology, and Aclarion saw significant declines.

Portfolio Pulse from Benzinga Insights

May 17, 2024 | 8:31 pm

The article highlights the performance of 12 healthcare stocks during Thursday's after-market session. Notable gainers include Scorpius Holdings (AMEX:SCPX), Kintara Therapeutics (NASDAQ:KTRA), and Doximity (NYSE:DOCS). Significant losers include TFF Pharmaceuticals (NASDAQ:TFFP), OptiNose (NASDAQ:OPTN), and Turnstone Biologics (NASDAQ:TSBX).

Portfolio Pulse from Benzinga Insights

May 16, 2024 | 8:31 pm

In Thursday's intraday session, several healthcare stocks experienced significant movements. Aclarion, Processa Pharma, Akso Health Group, Eyenovia, Predictive Oncology, and IMAC Holdings were among the gainers, with Aclarion leading by a 66.7% increase. On the downside, Cyclacel Pharmaceuticals, Organogenesis Holdings, Xylo Technologies, Protagenic Therapeutics, American Oncology Network, and INVO Bioscience saw notable declines, with Cyclacel Pharmaceuticals dropping by 33.1%.

Portfolio Pulse from Benzinga Insights

April 25, 2024 | 4:31 pm

Vaxxinity, Inc. announced its intention to voluntarily delist and deregister its Class A common stock, causing a sharp decline in its shares by around 55%. Other stocks experienced significant movements, with Matterport, Inc. seeing a jump due to an acquisition announcement by CoStar Group, and various companies reporting gains due to positive developments such as USDA approvals, IPO pricing, and compliance regains. Conversely, several companies faced declines due to negative news such as wind-down activities, delisting determinations, and price reductions.

Portfolio Pulse from Avi Kapoor

April 22, 2024 | 5:26 pm

Westport Fuel Systems Inc. (NASDAQ:WPRT) shares fell by approximately 10% after reporting a Q4 loss wider than expected. Other stocks experienced significant movements, with notable gainers including Stoke Therapeutics, Inc. (NASDAQ:STOK) and losers like Quhuo Limited (NASDAQ:QH). The movements were attributed to various factors including financial results, clinical trial data, and strategic agreements.

Portfolio Pulse from Avi Kapoor

March 26, 2024 | 5:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.